STARMED, a pioneer in innovative minimally invasive treatment solutions, has announced a comprehensive rebranding. Now in its ...

STARmed, a global pioneer in Radiofrequency Ablation (RFA) technology, today unveiled a new brand identity. The refreshed ...

Matching weight loss tools to the dominant drivers of weight regulation can lead to more effective, durable, and personalized ...

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

A mum of two received a devastating diagnosis after trusting her instincts during a shower. Claire Goldthorpe, 50, ...

Generation Z, millennials and Generation X are more likely to get colorectal cancer – but funding cuts could see the search for a cure grind to a halt.

Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX stock here.

Boston Scientific BSX has a stretched valuation, reflected in its Value Score of C. Shares of the company are trading at a forward five-year price/earnings (P/E) of 27.77X, above its median as well as ...

Khokhlova says the key to harnessing histotripsy’s benefits “will be combining ablation of the primary tumor in the pancreas with some other therapy.” Combination treatment could fight recurrent ...

The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.